| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A risk balancing act – Tourism competition using health leverage in the COVID-19 era
|
Grech, Victor
|
|
|
31 |
3 |
p. 121-130
|
article
|
| 2 |
Does COVID-19 teach us anything for our future?
|
Ralph Edwards, Ivor
|
|
|
31 |
3 |
p. 107-109
|
article
|
| 3 |
Dogs bark, but the caravan goes on: A discussion on the meta-analysis of antidepressants by Andrea Cipriani et al.
|
Makovec, Tomaž
|
|
|
31 |
3 |
p. 149-155
|
article
|
| 4 |
Inadequate evaluation of potential side effects of sildenafil in preterm stopped Dutch trial
|
Bijl, Dick
|
|
|
31 |
3 |
p. 145-148
|
article
|
| 5 |
In reply to: Presentation of benefits and harms of antidepressants on websites: A cross sectional study
|
Gossell-Williams, Maxine
|
|
|
31 |
3 |
p. 131-132
|
article
|
| 6 |
Patient safety issues associated with the use of compounded medicines as alternatives to approved pharmaceutical products in Europe and how best practice can improve outcomes
|
Isles, Mike
|
|
|
31 |
3 |
p. 133-144
|
article
|
| 7 |
Pharmaceutical cost analysis of dental diseases: An Indian scenario
|
Talreja, Pankaj
|
|
|
31 |
3 |
p. 165-177
|
article
|
| 8 |
Risk of using hydroxychloroquine as a treatment of COVID-19
|
Alanagreh, Lo’ai
|
|
|
31 |
3 |
p. 111-116
|
article
|
| 9 |
Some reflections on organizational profiles in Italy in the time of COVID-19
|
Bottari, Carlo
|
|
|
31 |
3 |
p. 117-119
|
article
|
| 10 |
What have antidepressants been tested for? A systematic review
|
Gøtzsche, Peter C.
|
|
|
31 |
3 |
p. 157-163
|
article
|
Journal description